Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome

This study investigated the effects of long-term treatment with rifaximin and the probiotic VSL#3 on uro-genital and gastrointestinal symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) plus diarrhoea-predominant irritable bowel syndrome (D-IBS) compared with patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicari, Enzo, Salemi, Michele, Sidoti, Giuseppe, Malaguarnera, Mariano, Castiglione, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707680/
https://www.ncbi.nlm.nih.gov/pubmed/29099760
http://dx.doi.org/10.3390/nu9111208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707680/
https://www.ncbi.nlm.nih.gov/pubmed/29099760
http://dx.doi.org/10.3390/nu9111208

Ejemplares similares